Illumina (ILMN)
(Delayed Data from NSDQ)
$122.28 USD
+1.23 (1.02%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $122.30 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ILMN 122.28 +1.23(1.02%)
Will ILMN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ILMN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ILMN
Illumina (ILMN) Expected to Beat Earnings Estimates: Should You Buy?
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
ILMN: What are Zacks experts saying now?
Zacks Private Portfolio Services
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive?
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Other News for ILMN
Interesting ILMN Put And Call Options For June 7th
Baron Focused Growth Fund Q1 2024 Shareholder Letter
Top high growth investment ratio stocks from each sector - GS
Engineering a Cool Career in Biotech - and Volunteering Along the Way
Evidence Supports Sequencing As First-Line Rare Disease Diagnostic